Understand Medication and Prescriptions

Size: px
Start display at page:

Download "Understand Medication and Prescriptions"

Transcription

1 Workbook 1 Understand Medication and Prescriptions Accountability Storage Administration Prescription Supply Legislation Level 2 Certificate in Understanding the Safe Handling of Medicines 1 L4W 2013

2 Information that should be supplied with medication Please read the following as it will help you to answer question 14. Patient Information Leaflet (PIL) The information supplied with medication is very important. It is a requirement of the MHRA that all medicine is supplied with a PIL. This applies to all medicines, including those bought over-the-counter or from a pharmacist, and those supplied on prescription. PILs should even be supplied when medicines are provided in a Monitored Dosage System. This information should always be readily available to your service users. By law, the information which must be supplied with all medication includes: Ingredients this includes the active ingredients of the medicine, as well as the ingredients used to make the tablet/capsule coating or the flavour/colour of the liquid. Dosage and administration this describes the strength of the medicine and how frequently it should be taken. Indications (uses) this should identify what the drug can be used for (e.g. to manage asthma or to treat certain types of infection). Contra-indications these are situations when the medicine should not be taken, or things that should not be done when taking the medication, e.g. not drinking alcohol during the course of the medication (it may alter its effectiveness); not suitable for certain age groups (e.g. children under 12); or if the person has another condition (e.g. is pregnant or has diabetes). Special precautions any special precautions that should be taken in order that the medicine is effective (e.g. take with food, or take on an empty stomach) or for certain groups of people (e.g. regular monitoring needed in individuals with renal/ kidney failure). Side effects any undesirable effects that the medicine may produce in some people (e.g. a rash or drowsiness). Interactions any interactions (reactions between two products) that the medicine may have with other drugs, which could be dangerous or make the treatment less effective. What to do if too much of the medication is taken. 42 L4W 2013

3 PIL should be written in clear and understandable terms, that both you and your service users can easily read. It should also contain the manufacturer and Product Licence Holder s names and addresses. Electronic copies of some PILs are available at Data sheets and Summaries of Product Characteristics (SPCs) In addition to the PIL aimed at service users, companies are also required to produce a Data Sheet and SPC for each medicine. These are much more detailed information sheets for use by health professionals. Copies of data sheets and SPCs are available from the Manufacturer and are also available electronically at Medicine instructions The pharmacist has overall responsibility for checking the prescription and ensuring that it is written correctly. When the pharmacist dispenses medication against a valid authorised prescription, the container in which the medication is supplied must be clearly labelled. By law, the label of any prescribed medicines dispensed by a pharmacist must include ALL of the following information: the service user s full name the name of the medication the dosage and frequency of the medication (for example how much and how often it should be taken) the date of supply the route to be taken/administered any special instructions for administration (for example take with food ) any warnings or cautions (for example avoid alcohol ) directions for use expiry date name and address of supplier/pharmacy the wording keep out of reach of children 43

4 Why is it important to seek information from the individual about their medication and condition? Please read the following as it will help you to answer question 15. Service users can be very useful sources of information. They often know a lot about their own condition and the medicines they are taking. They may be able to give you valuable information relating to: their medical condition and whether it is getting better or worse medicines which have not worked in the past and any side effects they have experienced with particular medicines any allergic reactions they have experienced with particular medicines how they prefer to take their medicine Person-centred care is an important aspect of supporting service users with their medication, and ongoing assessment of the individual s needs is essential to ensure that the person is fully supported. Giving someone the opportunity to discuss their requirements and any concerns they have can go a long way in increasing service user participation. If service users are consulted about their concerns and preferences, they are more likely to comply with their medication regime. In addition, all care staff have a responsibility to monitor the effectiveness of medication and to report any undesired effects. A person s condition can change from day to day or even hour to hour. It is important to establish whether the individual is experiencing any changes in condition, as this may be further affected by the medication the individual is taking. If service users are not given the opportunity to discuss their medication requirements and condition, they could be taking medication unnecessarily. 44 L4W 2013

5 Knowledge Activity 11: What sources of information are available to you within your workplace? Well done! You have now completed Workbook 1 and should attempt the assessments. If you require any help or guidance please contact your Assessor/Tutor. Workbook 1 45

6 Classification Monitoring Disclaimer Every effort has been made to ensure that the information contained within this learning material is accurate and reflects current best practice. All information provided should be used as guidance only, and adapted to reflect local practices and individual working environment protocols. All legislation is correct at the time of printing, but is liable to change (please ensure when referencing legislation that you are working from the most recent edition/amendment). Neither Learning for Work (L4W); nor their authors, publishers or distributors accept any responsibility for any loss, damage or injury (whether direct, indirect, incidental or consequential) howsoever arising in connection with the use of the information in this learning material. Copyright 2013 All rights reserved. All material contained within this manual, including (without limitation): text; logos; icons; and all other artwork is copyright material of Learning for Work (L4W), unless otherwise stated. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means (electronic, mechanical, photocopying, recording or otherwise), without the prior permission of the copyright owners. If you have any queries, feedback or need further information please contact: Learning for Work (a trading arm of Learning at Work Ltd). Pure Offices, 1 Broad Gate, The Headrow, Leeds LS1 8EQ info@learning-work.co.uk L4W-SHMv5 January 2013

Principles of Healthy Eating and Nutritional Needs of Individuals

Principles of Healthy Eating and Nutritional Needs of Individuals Workbook 1 Principles of Healthy Eating and Nutritional Needs of Individuals Physical Activity Food Sources Additives Nutrients Healthy diet Energy Eating Disorders Level 2 Certificate in Nutrition and

More information

SAMPLE. Certificate in Understanding Autism. Workbook 1 DIAGNOSIS PERSON-CENTRED. NCFE Level 2 ASPERGER S SYNDROME SOCIAL INTERACTION UNDERSTANDING

SAMPLE. Certificate in Understanding Autism. Workbook 1 DIAGNOSIS PERSON-CENTRED. NCFE Level 2 ASPERGER S SYNDROME SOCIAL INTERACTION UNDERSTANDING NCFE Level 2 Certificate in Understanding Autism ASPERGER S SYNDROME DIAGNOSIS AUTISM SPECTRUM CONDITION PERSON-CENTRED TRIAD OF IMPAIRMENTS UNDERSTANDING SOCIAL INTERACTION Workbook 1 Autism spectrum

More information

SAMPLE. Certificate in the Principles of End of Life Care PALLIATIVE CARE. Workbook 1. NCFE Level 2 ADVANCE CARE PLANNING COMMUNICATION SKILLS

SAMPLE. Certificate in the Principles of End of Life Care PALLIATIVE CARE. Workbook 1. NCFE Level 2 ADVANCE CARE PLANNING COMMUNICATION SKILLS NCFE Level 2 Certificate in the Principles of End of Life Care COMMUNICATION SKILLS UNDERSTANDING GRIEF AND LOSS PALLIATIVE CARE CARE PLANNING CYCLE ADVANCE CARE PLANNING Workbook 1 This section of the

More information

SAMPLE. Certificate in Understanding Autism. Workbook 1 DIAGNOSIS PERSON-CENTRED. CACHE Level 2 ASPERGER SYNDROME SOCIAL INTERACTION UNDERSTANDING

SAMPLE. Certificate in Understanding Autism. Workbook 1 DIAGNOSIS PERSON-CENTRED. CACHE Level 2 ASPERGER SYNDROME SOCIAL INTERACTION UNDERSTANDING CACHE Level 2 Certificate in Understanding Autism ASPERGER SYNDROME DIAGNOSIS Workbook 1 TRIAD OF IMPAIRMENTS UNDERSTANDING AUTISM SPECTRUM CONDITION PERSON-CENTRED SOCIAL INTERACTION In this section,

More information

Certificate in the Principles of Dementia Care

Certificate in the Principles of Dementia Care CACHE Level 2 Certificate in the Principles of Dementia Care LE EQUALITY AND DIVERSITY ACTIVITIES P INTERACTION M PERSON-CENTRED SA MEDICATION Workbook 1 COMMUNICATION In this section, you will learn about

More information

Certificate in the Principles of the Prevention and Control of Infection in Health Care Settings

Certificate in the Principles of the Prevention and Control of Infection in Health Care Settings CACHE Level 2 Certificate in the Principles of the Prevention and Control of Infection in Health Care Settings LE COLONISATION PREVENTION M P BACTERIA SA DECONTAMINATION Workbook 1 HYGIENE LEGISLATION

More information

SAMPLE. Certificate in Understanding Nutrition and Health. Workbook 1 HEALTHY DIET NUTRIENTS. CACHE Level 2 EATING DISORDERS ENERGY PHYSICAL ACTIVITY

SAMPLE. Certificate in Understanding Nutrition and Health. Workbook 1 HEALTHY DIET NUTRIENTS. CACHE Level 2 EATING DISORDERS ENERGY PHYSICAL ACTIVITY CACHE Level 2 Certificate in Understanding Nutrition and Health PHYSICAL ACTIVITY HEALTHY DIET Workbook 1 NUTRIENTS ADDITIVES FOOD SOURCES ENERGY EATING DISORDERS In this section you will look at how diet

More information

Certificate in the Principles of End of Life Care

Certificate in the Principles of End of Life Care CACHE Level 2 Certificate in the Principles of End of Life Care LE COMMUNICATION SKILLS CARE PLANNING CYCLE M P UNDERSTANDING GRIEF AND LOSS SA PALLIATIVE CARE Workbook 1 ADVANCE CARE PLANNING This section

More information

SAMPLE. Certificate in Understanding Behaviour that Challenges. Workbook 1 CONFLICT. CACHE Level 2 SUPPORT SYSTEMS POSITIVE REINFORCEMENT

SAMPLE. Certificate in Understanding Behaviour that Challenges. Workbook 1 CONFLICT. CACHE Level 2 SUPPORT SYSTEMS POSITIVE REINFORCEMENT CACHE Level 2 Certificate in Understanding Behaviour that Challenges BEHAVIOUR THAT CHALLENGES CONFLICT ATTITUDES AND UNDERSTANDING PATTERNS OF BEHAVIOUR POSITIVE REINFORCEMENT SUPPORT SYSTEMS Workbook

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If

More information

Lidocaine adult mouthwash 2mg in 1ml. Information for patients Pharmacy

Lidocaine adult mouthwash 2mg in 1ml. Information for patients Pharmacy Lidocaine adult mouthwash 2mg in 1ml Information for patients Pharmacy This leaflet contains important information about your medicine, please read it carefully. If you have any questions, contact your

More information

PIL. ParaCet Flu 500 mg+250 mg/sachet Powder for oral solution paracetamol + ascorbic acid

PIL. ParaCet Flu 500 mg+250 mg/sachet Powder for oral solution paracetamol + ascorbic acid PIL ParaCet Flu 500 mg+250 mg/sachet Powder for oral solution paracetamol + ascorbic acid Please, carefully read this PIL before you start using the medicine. This medicine is available without prescription,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking Easofen Max Strength Tablets because it contains

More information

Quality, Safety and Sourcing in Unlicensed Medicines

Quality, Safety and Sourcing in Unlicensed Medicines Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?

More information

Bonefos 400 mg capsules sodium clodronate

Bonefos 400 mg capsules sodium clodronate Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate) PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate) Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)

Package Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide) Package Leaflet: INFORMATION FOR THE USER PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide) Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol Patient leaflet: Information for the user Paracetamol Galpharm 500mg tablets paracetamol [For medicines available only on prescription:] Read all of this leaflet carefully before you start taking this

More information

Patient Information Leaflet

Patient Information Leaflet Patient Information Leaflet Ibuprofen 5% w/w Gel Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions

More information

Pain relief after birth and while breastfeeding. Information for mothers

Pain relief after birth and while breastfeeding. Information for mothers Pain relief after birth and while breastfeeding Information for mothers Who is this leaflet for? This leaflet has been written to provide advice on suitable pain relief following the birth of your baby.

More information

Ventolin Accuhaler 200 micrograms salbutamol sulfate

Ventolin Accuhaler 200 micrograms salbutamol sulfate Package Leaflet: Information for the User Ventolin Accuhaler 200 micrograms salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Certificate in Understanding Common Childhood Illnesses

Certificate in Understanding Common Childhood Illnesses CACHE Level 2 Certificate in Understanding Common Childhood Illnesses LE SPREAD OF INFECTION POLICIES AND PROCEDURES M P HEALTHY ENVIRONMENTS SA SIGNS AND SYMPTOMS Workbook 1 ALLERGIES ACUTE AND CHRONIC

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg Tablets sodium fusidate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

All Saints First School Administering of Medicines Policy

All Saints First School Administering of Medicines Policy All Saints First School Administering of Medicines Policy Success Indicators The following indicators will demonstrate the level of compliance with this policy and its procedures: a) Employees who are

More information

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine. PHOLCODINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains pholcodine. This leaflet is intended to provide information on the active ingredient

More information

Drug Information Sheet("Kusuri-no-Shiori")

Drug Information Sheet(Kusuri-no-Shiori) Drug Information Sheet("Kusuri-no-Shiori") The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse

More information

Lidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel. Information for patients Pharmacy

Lidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel. Information for patients Pharmacy Lidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel Information for patients Pharmacy This leaflet contains important information about your medicine; please read it carefully. If you

More information

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Ca-C 1000 Calvive 1000 mg + 327 mg + 1000 mg effervescent tablets CALCIUM LACTATE GLUCONATE, CALCIUM CARBONATE, ASCORBIC ACID (VITAMIN C) This leaflet is a copy

More information

Testing Railway Safety Critical Workers for Drugs and Alcohol

Testing Railway Safety Critical Workers for Drugs and Alcohol Uncontrolled When Printed Railway Group Standard Testing Railway Safety Critical Workers for Drugs and Alcohol Synopsis This document mandates common requirements for drug and alcohol testing of staff

More information

Package leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate

Package leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate Package leaflet: Information for the user Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION CLASSIFICATION OF DOCUMENT: PURPOSE: Patient Group Direction Document

More information

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine. TRIPROLIDINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains triprolidine. This leaflet is intended to provide information on the active ingredient

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg/5 ml Oral Suspension fusidic acid Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol) Package leaflet: Information for the user Colecalciferol 3000 IU/ml Oral Solution (colecalciferol) Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the user. Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

Package leaflet: Information for the user. Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal) Package leaflet: Information for the user Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal) This medicine is subject to additional monitoring. This will allow quick identification

More information

POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health POISONS SCHEDULING Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health Topics Schedules of the Poisons Standard (Cth) Poisons and Therapeutic Goods Act 1966

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) PACKAGE LEAFLET: INFORMATION FOR THE USER DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need

More information

ICD-10 Readiness (*9/14/15) By PracticeHwy.com, Inc.

ICD-10 Readiness (*9/14/15) By PracticeHwy.com, Inc. ICD-10 Readiness (*9/14/15) By PracticeHwy.com, Inc. Notice Information in this document is subject to change without notice and does not represent a commitment on the part of PracticeHwy.com, Inc. Companies,

More information

IBS Relief 135 mg Tablets Mebeverine Hydrochloride

IBS Relief 135 mg Tablets Mebeverine Hydrochloride PATIENT INFORMATION LEAFLET IBS Relief 135 mg Tablets Mebeverine Hydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription.

More information

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate PACKAGE LEAFLET 1 Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate Package leaflet: Information for the user Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains

More information

This leaflet answers some common questions about Momex SR Tablets.

This leaflet answers some common questions about Momex SR Tablets. Momex SR Modified (Sustained) Release Tablets [Morphine sulphate] CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Momex SR Tablets. It does not contain

More information

Artemether 20mg/lumefantrine 120mg WHOPAR part 5 12/2011 Dispersible tablets (Novartis Pharma AG), MA069 LABELLING. Page 1 of 6

Artemether 20mg/lumefantrine 120mg WHOPAR part 5 12/2011 Dispersible tablets (Novartis Pharma AG), MA069 LABELLING. Page 1 of 6 LABELLING Page 1 of 6 PARTICULARS TO APPEAR ON THE OUTER PACKAGE CARTON OF UNIT PACK 1. NAME OF THE MEDICINAL PRODUCT Coartem Dispersible Artemether/Lumefantrine 2. STATEMENT OF ACTIVE SUBSTANCE(S) Artemether

More information

Guidance on Bulk Prescribing for Care Home Residents

Guidance on Bulk Prescribing for Care Home Residents Guidance on Bulk Prescribing for Care Home Residents There are many residents in care homes taking medicines when required, which may present problems for the prescriber in determining the quantity to

More information

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

Ventolin Injection 500 micrograms/ml salbutamol sulfate

Ventolin Injection 500 micrograms/ml salbutamol sulfate Package leaflet: Information for the user Ventolin Injection 500 micrograms/ml salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Unit 204 Assist with the assembly of prescribed items

Unit 204 Assist with the assembly of prescribed items Element 1 Assemble prescribed 171 172 Element 1 Assemble prescribed Background Assembling prescribed is a complex process. The two main components of this process are labelling and dispensing. It is essential

More information

Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy

Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy Introduction 1. The consolidation and review of the UK medicines legislation (including the Medicines

More information

This leaflet answers some common questions about TIBERAL tablets.

This leaflet answers some common questions about TIBERAL tablets. Consumer Medicine Information Tiberal Ornidazole 500mg film-coated tablets What is in this leaflet This leaflet answers some common questions about TIBEAL tablets. It does not contain all the available

More information

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe.

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe. CONSUMER MEDICINE INFORMATION Levetiracetam generichealth Levetiracetam tablets What is in this leaflet Please read this leaflet carefully before you take this medicine. This leaflet answers some common

More information

247 CMR BOARD OF REGISTRATION IN PHARMACY

247 CMR BOARD OF REGISTRATION IN PHARMACY 247 CMR 18.00: NON-STERILE COMPOUNDING Section 18.01: Authority and Purpose 18.02: Non-Sterile Compounding Process 18.03: Non-Sterile Compounding Facility 18.04: Non-Sterile Compounding Equipment 18.05:

More information

MATERIAL SAFETY DATA SHEET WILKINSONS GROUT CLEANER

MATERIAL SAFETY DATA SHEET WILKINSONS GROUT CLEANER MATERIAL SAFETY DATA SHEET WILKINSONS GROUT CLEANER 1. IDENTIFICATION OF THE PREPARATION AND THE COMPANY: SUBSTANCE NAME: Wilkinsons Grout Cleaner APPLICATIONS: Wilkinsons SUPPLIER: Business Park Abergele

More information

Prescription only medicines (POMs)

Prescription only medicines (POMs) Prescription only medicines (POMs) 2017 Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations

More information

Nova Scotia Drug Information System

Nova Scotia Drug Information System Nova Scotia Drug Information System Functions Presentation Details: Slides: 19 Duration: 00:32:04 Filename: DIS Module4.Functions.ppt Presenter Details: Slide 1 Nova Scotia Drug Information System Duration:

More information

Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY

Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY Statutory Instrument 120 of 2016 Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) [Cap 15:05 Section 1 Title 2 Interpretation ARRANGEMENT OF SECTIONS PART I PRELIMINARY 3 Inspection

More information

Ketorolac injection. Supportive care

Ketorolac injection. Supportive care Supportive care Ketorolac injection Supportive care: specialist medicines This leaflet provides information on a medicine called ketorolac which is used to treat pain that is difficult to control. It is

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE

PACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE PACKAGE LEAFLET: INFORMATION FOR THE USER BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to

More information

What is in this leaflet

What is in this leaflet Package leaflet: Information for the user 2.5 mg film-coated tablets Naratriptan Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin Package leaflet: Information for the patient NEGABAN 1g, powder for solution for injection or infusion Temocillin Read all of this leaflet carefully before you start using this medicine because it contains

More information

HAVRIX 1440 and HAVRIX Junior

HAVRIX 1440 and HAVRIX Junior HAVRIX 1440 and HAVRIX Junior Inactivated Hepatitis A Virus Vaccine Consumer Medicine Information Leaflet In this leaflet, HAVRIX refers to the use of both HAVRIX 1440 for adults and HAVRIX Junior for

More information

XYZAL 5 MG FILM-COATED TABLET

XYZAL 5 MG FILM-COATED TABLET XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,

More information

PREREQUISITES: VETA 1104, VETA 1201 and MATH This class must be taken before or in conjunction with VETT 2100.

PREREQUISITES: VETA 1104, VETA 1201 and MATH This class must be taken before or in conjunction with VETT 2100. COURSE: VETT 2102 - Pharmacology for Veterinary Technicians CRN: CREDIT HOURS (Lecture/Lab/Total): 3/0/3 CONTACT HOUR (Lecture/Lab/Total): 45/0/45 INSTRUCTOR INFORMATION Name: Shawna Guidry Email: shawnaguidry@northshorecollege.edu

More information

PATIENT INFORMATION LEAFLET DYNAFIL RANGE

PATIENT INFORMATION LEAFLET DYNAFIL RANGE Scheduling Status: S4 Proprietary name, Strength and Pharmaceutical Form: DYNAFIL 25 mg (coated tablets) DYNAFIL 50 mg (coated tablets) DYNAFIL 100 mg (coated tablets) Please read this leaflet carefully

More information

Thailand s experience in developing the Reclassification guideline

Thailand s experience in developing the Reclassification guideline Ms.Charunee Krisanaphan Pharmacist, Senior Professional level Standards and Regulations Division, Bureau of Control Thai Food and October 22, 2014 Outlines Definition Existed guideline Process of developing

More information

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol) Package leaflet: Information for the user Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol) Read all of this leaflet carefully before you start taking this medicine because

More information

Guideline for the Rational Use of Controlled Drugs

Guideline for the Rational Use of Controlled Drugs Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import

More information

LGP CLASSIC Oil Products

LGP CLASSIC Oil Products LGP CLASSIC Oil Products Patient Information Leaflet (PIL) PRODUCT RANGE Medicinal Cannabis Oil Extract LGP CLASSIC 10:10 LGP CLASSIC 10:15 LGP CLASSIC 20:5 What is in this leaflet Please read this leaflet

More information

Guide to using your Medicine Safely

Guide to using your Medicine Safely Guide to using your Medicine Safely Resthaven Incorporated January 2014 ABN 79 976 580 833 This document is copyright and may not be reproduced or copied in any form, or scanned or stored in any type of

More information

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid)

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid) PATIENT INFORMATION LEAFLET Nu-Seals 75 aspirin (acetylsalicylic acid) Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you

More information

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET TRAMADOG, solution for injection Decentralised Procedure D195 February 2018 V3 Tramadol HCl 50 mg/ml Part 1.B SPC, Labelling and Package Leaflet PART 1.B SPC, LABELLING AND PACKAGE LEAFLET 1B- 1 ANNEX

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate PACKAGE LEAFLET: INFORMATION FOR THE USER Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Emerade 150 micrograms solution for injection in pre-filled pen Emerade 300 micrograms solution for injection in pre-filled pen Emerade 500 micrograms solution

More information

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS AUDIT TOOL FOR DISPENSING SERVICES COMPILED BY: Lynn Morrison ISSUE 1 CHECKED BY: Colette Byrne NUMBER: ISSUE DATE: 01.12.07 SUPERSEDES: NEW REVIEW DATE: 01.12.09 AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE

More information

Patient Group Directions (PGDs)

Patient Group Directions (PGDs) Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical

More information

Consumer Medicine Information

Consumer Medicine Information Consumer Medicine Information Trade Name: ZOLPIDEM-DP Active Ingredient: Zolpidem tartrate Warning: Zolpidem may be associated with unusual and potentially dangerous behaviours whilst apparently asleep.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER ARICEPT Evess 5 mg Orodispersible Tablets ARICEPT Evess 10 mg Orodispersible Tablets (Donepezil Hydrochloride) You and your caregiver should read all of this leaflet

More information

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides Package leaflet: Information for the user SenEase 7.5 mg tablets Sennosides Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep

More information

Getting the best from the medicines you buy

Getting the best from the medicines you buy Getting the best from the medicines you buy You can buy many medicines without needing to see your doctor. These are often called over-the-counter medicines. They are safe and effective as long as you

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may

More information

Pain relief after day surgery

Pain relief after day surgery Pain relief after day surgery Anaesthetics Department Patient Information Leaflet Introduction This leaflet is to help you with pain relief after you have day surgery. It gives information on: The types

More information

THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: Patient Group Direction for Pneumococcal polysaccharide vaccine VERSION: PNEUMOCOCCAL POLY-2013.1 (Pneumovax II ) Start 1 st May 2013 Expiry 30 th April 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED

More information

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service

More information

Some general information on hepatitis A infection is given at the end of this leaflet.

Some general information on hepatitis A infection is given at the end of this leaflet. Package Leaflet: Information for the User Havrix Monodose Vaccine Suspension for injection in a pre-filled syringe Hepatitis A (inactivated) vaccine (adsorbed) Read all of this leaflet carefully before

More information

Package leaflet: Information for the patient. ROBAXIN mg Film-coated tablets for oral use Methocarbamol. 100 Tablets

Package leaflet: Information for the patient. ROBAXIN mg Film-coated tablets for oral use Methocarbamol. 100 Tablets Package leaflet: Information for the patient ROBAXIN - 750 750 mg Film-coated tablets for oral use Methocarbamol 100 Tablets Dosage: 2 tablets to be swallowed 4 times a day or as directed by your doctor.

More information

Lesson 8 Using Medicines in Safe Ways

Lesson 8 Using Medicines in Safe Ways Lesson 8 Using Medicines in Safe Ways Overview Students identify symptoms or signals the body sends when a person is sick. They define medicine and learn the difference between prescription and over-the-counter

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) Pfizer Logo Read all of this leaflet carefully before you start taking this

More information

Latex allergy. Occupational aspects of management

Latex allergy. Occupational aspects of management Latex allergy Occupational aspects of management for Evidence-based guidance employees This leaflet is about what to do if you are allergic to latex used at work, and measures that can be taken to minimise

More information

PATIENT INFORMATION LEAFLET TEXAMER

PATIENT INFORMATION LEAFLET TEXAMER SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM: film-coated tablets Read all of this leaflet carefully because it contains important information for you. is available without a doctor s prescription,

More information

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir Package leaflet: Information for the user Famvir 125, 250 and 500 mg film-coated tablets famciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration : Information for the user HEPATECT CP 50 IU/ml solution for infusion Human hepatitis B immunoglobulin for intravenous administration Read all of this leaflet carefully before you start using this medicine

More information

MODULE 1: BASIC DRUG KNOWLEDGE

MODULE 1: BASIC DRUG KNOWLEDGE MODULE 1: BASIC DRUG KNOWLEDGE 1.1 How Drugs Work A drug is a medicine or substance (but not food or water) which when ingested (or otherwise introduced into the body) alters the way the body works physically

More information

Jylamvo 2 mg/ml oral solution (Methotrexate) Guide for Healthcare Professionals. Information to minimise the risk of medication error

Jylamvo 2 mg/ml oral solution (Methotrexate) Guide for Healthcare Professionals. Information to minimise the risk of medication error 2 mg/ml oral solution (Methotrexate) Guide for Healthcare Professionals Information to minimise the risk of medication error NOTE: Special warnings and precautions for use - This oral solution contains

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Meptid 100 mg/ml Solution for Injection. Meptazinol

PACKAGE LEAFLET: INFORMATION FOR THE USER. Meptid 100 mg/ml Solution for Injection. Meptazinol PACKAGE LEAFLET: INFORMATION FOR THE USER Meptid 100 mg/ml Solution for Injection Meptazinol Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need

More information

URSOSAN 250mg capsule, hard

URSOSAN 250mg capsule, hard PACKAGE LEAFLET: INFORMATION FOR THE USER URSOSAN 250mg capsule, hard URSODEOXYCHOLIC ACID This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

GLUCOPHAGE 500 mg Merck Serono

GLUCOPHAGE 500 mg Merck Serono GLUCOPHAGE 500 mg Film-coated tablets Composition Film-coated tablets containing 500 mg of metformin (INN) hydrochloride (equivalent to 390 mg of metformin Excipients Polyvidone K 30, magnesium stearate,

More information

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: SCHEDULING STATUS: S2 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: TEXA 10 mg (tablets) TEXA SYRUP (syrup) Read this entire leaflet carefully before you start taking TEXA. Keep this leaflet. You

More information

DRYDEN AQUA LTD Safety Data Sheet 18

DRYDEN AQUA LTD Safety Data Sheet 18 DRYDEN AQUA LTD Safety Data Sheet 18 According to Regulation (EC) No. 1907/2006 Date of compilation: 04/12/12 Print date: 03/02/13 Section 1 Identification of the substance/mixture and of the company/undertaking

More information